Hans Stoop

44.6k citations

92 papers · 6.3k indexed · 2 hit papers · h-index 44

Co-authors: Leendert H. J. Looijenga J. Wolter Oosterhuis Ad Gillis Carsten Bokemeyer Friedemann Honecker Katja P. Wolffenbuttel Remko Hersmus Martine Cools
Topics: Testicular diseases and treatments (63 papers)Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (25 papers)Renal and related cancers (22 papers)
Cited by: Reproductive Medicine Cancer Research Surgery
Journals: Cell The Journal of Experimental Medicine Journal of Clinical Oncology
Partner nations: Netherlands Germany United States

In The Last Decade

Hans Stoop

91 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors

2006 1.0k citations P. Mathijs Voorhoeve, Carlos le Sage et al. Cell profile →
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

2003 502 citations Leendert H. J. Looijenga, Hans Stoop et al. profile →

Peers

Countries citing papers authored by Hans Stoop

Since Specialization

Citations

This map shows the geographic impact of Hans Stoop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Stoop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Stoop more than expected).

Fields of papers citing papers by Hans Stoop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Stoop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Stoop. The network helps show where Hans Stoop may publish in the future.

Co-authorship network of co-authors of Hans Stoop

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Stoop. A scholar is included among the top collaborators of Hans Stoop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Stoop. Hans Stoop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness 2020 ·Cancer Cell International ·Silvia Schmidtova,Lambert C. J. Dorssers,Katarína Kaľavská,Ad Gillis,J. Wolter Oosterhuis,Hans Stoop,Svetlana Miklikova,Zuzana Kozovská,Monika Buríková,(unknown),Erika Durinikova,Michal Chovanec,Michal Mego,Lucia Kučerová,Leendert H. J. Looijenga	18
2	Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma 2019 ·PLoS ONE ·(unknown),(unknown),(unknown),Hans Stoop,Michail Doukas,Daan Nieboer,Manon C.W. Spaander,J. Jan B. van Lanschot,Bas P. L. Wijnhoven,Arjun D. Koch,Marco J. Bruno,Leendert H. J. Looijenga,Katharina Biermann	7
3	Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development 2019 ·British Journal of Cancer ·Lambert C. J. Dorssers,Ad Gillis,Hans Stoop,Ronald van Marion,Marleen M. Nieboer,Job van Riet,Harmen J.G. van de Werken,J. Wolter Oosterhuis,Jeroen de Ridder,Leendert H. J. Looijenga	29
4	Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer 2017 ·American Journal Of Pathology ·(unknown),Anieta M. Sieuwerts,Vanja de Weerd,Hans Stoop,John W.M. Martens,Carolien H. M. van Deurzen	25
5	NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development 2016 ·Genetics in Medicine ·(unknown),Hans Stoop,Frank Peelman,Anne‐Laure Todeschini,Toon Rosseel,Frauke Coppieters,Reiner A. Veitia,Leendert H. J. Looijenga,Elfride De Baere,Martine Cools	90
6	SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype 2012 ·BMC Medical Genetics ·Remko Hersmus,Hans Stoop,Erin Turbitt,J. Wolter Oosterhuis,Stenvert L. S. Drop,Andrew Sinclair,Stefan J. White,Leendert H. J. Looijenga	15
7	Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment‐resistance 2011 ·International Journal of Andrology ·Leendert H. J. Looijenga,Ad Gillis,Hans Stoop,Katharina Biermann,J. Wolter Oosterhuis	55
8	Diagnosis of testicular carcinoma in situ‘(intratubular and microinvasive)’ seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections 2011 ·Histopathology ·Hans Stoop,Wim J. Kirkels,Gert R. Dohle,Ad Gillis,Michael A. den Bakker,Katharina Biermann,Wolter Oosterhuis,Leendert H. J. Looijenga	19
9	Microsatellite Instability, Mismatch Repair Deficiency, and BRAF Mutation in Treatment-Resistant Germ Cell Tumors 2009 ·Journal of Clinical Oncology ·Friedemann Honecker,Hendrik Wermann,Frank Mayer,Ad Gillis,Hans Stoop,(unknown),Karin Oechsle,Ewout W. Steyerberg,(unknown),Winand N.M. Dinjens,J. Wolter Oosterhuis,Carsten Bokemeyer,Leendert H. J. Looijenga	134
10	Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory 2008 ·International Journal of Andrology ·Niels J. van Casteren,Jeroen de Jong,Hans Stoop,Ewout W. Steyerberg,Esther W. de Bekker‐Grob,Gert R. Dohle,J. Wolter Oosterhuis,Leendert H. J. Looijenga	30
11	Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours 2007 ·International Journal of Andrology ·Leendert H. J. Looijenga,Ad Gillis,Hans Stoop,Remko Hersmus,J. Wolter Oosterhuis	44
12	Chromosomes and Expression in Human Testicular Germ‐Cell Tumors 2007 ·Annals of the New York Academy of Sciences ·Leendert H. J. Looijenga,Ad Gillis,Hans Stoop,Remko Hersmus,J. Wolter Oosterhuis	58
13	Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene 2006 ·Cancer Research ·Leendert H. J. Looijenga,Remko Hersmus,Ad Gillis,Rolph Pfundt,Hans Stoop,Ruud J. H. L. M. van Gurp,Joris A. Veltman,H. Berna Beverloo,Ellen van Drunen,Ad Geurts van Kessel,Renee A. Reijo Pera,Dominik T. Schneider,Brenda Summersgill,Janet Shipley,Alan McIntyre,Peter J. van der Spek,Eric Schoenmakers,J. Wolter Oosterhuis	170
14	A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumorsbreakdown → 2006 ·Cell ·P. Mathijs Voorhoeve,Carlos le Sage,Mariëtte Schrier,Ad Gillis,Hans Stoop,Remco Nagel,Ying Poi Liu,(unknown),Jarno Drost,Alexander Griekspoor,Eitan Zlotorynski,Norikazu Yabuta,Gabriella De Vita,Hiroshi Nojima,Leendert H. J. Looijenga,Reuven Agami	1023
15	Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors 2005 ·Human Pathology ·Martine Cools,Friedemann Honecker,Hans Stoop,Joris D. Veltman,Ronald R. de Krijger,Ewout W. Steyerberg,Katja P. Wolffenbuttel,Carsten Bokemeyer,Yun‐Fai Chris Lau,Stenvert L. S. Drop,Leendert H. J. Looijenga	38
16	Diagnostic value of OCT3/4 for pre‐invasive and invasive testicular germ cell tumours 2005 ·The Journal of Pathology ·Jeroen de Jong,Hans Stoop,Gert R. Dohle,Chris H. Bangma,Mike Kliffen,(unknown),Martin J. van den Bent,Johan M. Kros,J. Wolter Oosterhuis,Leendert H. J. Looijenga	123
17	Identification of recurrent chromosomal aberrations in germ cell tumors of neonates and infants using genomewide array‐based comparative genomic hybridization 2005 ·Genes Chromosomes and Cancer ·Imke M. Veltman,Joris A. Veltman,Irene M. Janssen,Christina Hulsbergen‐van de Kaa,Wolter Oosterhuis,Dominik T. Schneider,Hans Stoop,Ad Gillis,Susanne Zahn,Leendert H. J. Looijenga,U. Göbel,Ad Geurts van Kessel	32
18	Germ cell lineage differentiation in non‐seminomatous germ cell tumours 2005 ·The Journal of Pathology ·Friedemann Honecker,Hans Stoop,Frank Mayer,Carsten Bokemeyer,Diego H. Castrillón,Yun‐Fai Chris Lau,Leendert H. J. Looijenga,J. Wolter Oosterhuis	63
19	A novel case of infantile sacral teratoma and a constitutional t(12;15)(q13;q25) pat 2002 ·Cancer Genetics and Cytogenetics ·Imke M. Veltman,Martien van Asseldonk,Marga Schepens,Hans Stoop,Leendert H. J. Looijenga,Carine Wouters,Lutgarde Govaerts,Ron F. Suijkerbuijk,Ad Geurts van Kessel	12
20	Restricted 12p Amplification and RAS Mutation in Human Germ Cell Tumors of the Adult Testis 2000 ·American Journal Of Pathology ·Helene Roelofs,Marijke Mostert,(unknown),Gaetano Zafarana,(unknown),Ruud J. H. L. M. van Gurp,Ad Gillis,Hans Stoop,Berna Beverloo,J. Wolter Oosterhuis,Carsten Bokemeyer,Leendert H. J. Looijenga	82

About Hans Stoop

Hans Stoop is a scholar working on Reproductive Medicine, Surgery and Rheumatology, having authored 92 papers that have together received 6.3k indexed citations. Recurring topics across this work include Testicular diseases and treatments (63 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (25 papers) and Renal and related cancers (22 papers). The work is most often cited by research in Reproductive Medicine (1.2k citations), Cancer Research (1.2k citations) and Surgery (3.1k citations). Hans Stoop has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Leendert H. J. Looijenga, J. Wolter Oosterhuis, Ad Gillis, Carsten Bokemeyer, Friedemann Honecker, Katja P. Wolffenbuttel, Remko Hersmus, Martine Cools, Alexander Griekspoor and Eitan Zlotorynski. Their work appears in journals such as Cell, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact